Pregnancy and birth emergencies
Amniotic fluid embolism: what it is, how common it is and outcomes
Amniotic fluid embolism (AFE) is a rare and sudden obstetric emergency in which a woman collapses during labour or soon after birth. It cannot be predicted or prevented, and diagnosis is clinical. This guide summarises what UK surveillance and research report about how it is defined, how often it occurs, associated factors and outcomes, written for people who want to understand the condition.
Last checked: 2026-10-10
Key facts
At a glance.
-
Very rare
The UK Obstetric Surveillance System (UKOSS) says estimates of incidence vary between 1 in 8,000 and 1 in 80,000 pregnancies.
-
A leading cause of maternal death
UKOSS says AFE has been identified by the UK Confidential Enquiry into Maternal Deaths as a leading cause of maternal mortality, with some evidence that fatality is decreasing.
-
Clinical diagnosis
The UK case definition is a clinical diagnosis of acute hypotension or cardiac arrest, acute hypoxia or coagulopathy with no other potential explanation, or a pathological finding of fetal squames or hair in the lungs.
-
No clear predictors
UKOSS says no clear risk factors are identifiable from previous cases, though a larger multicountry study found associations with older maternal age, multiple pregnancy, placenta praevia and induction of labour.
-
Serious outcomes
A multicountry study including UK data found that 30% to 41% of women with AFE died or had permanent neurological injury, depending on the case definition.
-
Supportive care
The same study suggested immediate supportive obstetric care, senior obstetric and anaesthetic presence and treatment of clotting problems may be important.
What amniotic fluid embolism is
Amniotic fluid embolism (AFE) is a rare obstetric emergency. It typically presents as a sudden collapse of the mother around the time of labour or birth, with problems affecting the heart, lungs and blood clotting.
UKOSS, which is based at the National Perinatal Epidemiology Unit in Oxford, defines cases for surveillance using either a clinical diagnosis or a pathological one. The clinical definition is acute hypotension or cardiac arrest, acute hypoxia or coagulopathy in the absence of any other potential explanation for the symptoms and signs. The pathological definition is the presence of fetal squames or hair in the lungs.
Because there is no single test that confirms it during life, doctors diagnose AFE when a woman has this pattern of sudden collapse and no other cause is found. This is why numbers vary between studies and countries.
How common it is
UKOSS reports that estimates of incidence vary between 1 in 8,000 and 1 in 80,000 pregnancies, and that estimates of the mortality rate vary widely too, from as much as 86% to more recent estimates of 16% to 30%. The variation reflects different definitions and how cases are identified.
A pooled analysis from five countries including the UK, led from Oxford and published in PLOS Medicine in 2019, estimated the incidence of AFE at 0.8 to 1.8 per 100,000 maternities depending on the case definition. In other words, it is extremely uncommon, and most pregnant women will never encounter it.
Associated factors
UKOSS says no clear risk factors are identifiable from previous cases, though some preliminary evidence suggests that earlier diagnosis may lead to better outcomes. The multicountry study using UK and Australian control data found that some factors were associated with higher odds of AFE. Association is not the same as cause, and none of these factors means that AFE will happen.
| Factor | Finding |
|---|---|
| Maternal age | Older maternal age (35 or more) was associated with higher odds |
| Multiple pregnancy | Associated with significantly raised odds |
| Placenta praevia and placental abruption | Associated with significantly raised odds |
| Polyhydramnios | Associated with raised odds |
| Induction of labour | Using any method, associated with raised odds |
How it presents
AFE is a sudden event. The UK definition describes acute hypotension or cardiac arrest, acute hypoxia, and coagulopathy, which means the blood fails to clot properly and bleeding can follow. The multicountry study found that women who died were more likely to present with cardiac arrest than those who survived.
Because it is an in-hospital emergency, there is no self-management advice. Any woman in labour or soon after birth who suddenly becomes breathless, unwell or collapses needs immediate help from the maternity team. Outside hospital, such as after a home birth, 999 should be called.
Emergency care
The researchers behind the multicountry study concluded that when AFE is suspected, initial supportive obstetric care is important, and that having an obstetrician and anaesthetist present at the time and interventions to correct coagulopathy, including an adequate dose of tranexamic acid, may be important to improve maternal outcome.
In practice this means a team approach: resuscitation if the heart stops, support for breathing and circulation, treatment of bleeding and clotting problems, and delivery of the baby if the woman is still pregnant. Intensive care is often needed for women who survive the first stage.
Outcomes and recovery
UKOSS says there is some evidence that fatality is decreasing in the UK. The multicountry study, which pooled data from Australia, France, the Netherlands, Slovakia and the UK, reported that the proportion of women with AFE who died or had permanent neurological injury ranged from 30% to 41%, depending on the case definition.
This means many women survive, and some have lasting effects. Recovery after an AFE may involve intensive care, rehabilitation and psychological support for the woman and her family, and babies may also need neonatal care.
Emotional recovery matters as much as physical recovery. It is reasonable to ask the maternity service for a debrief so that you can ask what happened and what it means for future pregnancies.
Future pregnancies and support
Women who have survived AFE, and families who have lost someone, often ask about the chance of recurrence and whether another pregnancy is safe. The sources reviewed for this page do not give figures for recurrence, so this is a conversation to have with an obstetrician, ideally in a debrief or pre-pregnancy appointment after the event.
Local maternity services can advise on support for bereaved families, peer support and counselling. A GP can also help with referrals for mental health support.
NHS route or private care
AFE is managed as an emergency in the unit where the woman is giving birth, whether NHS or private.
Surveillance through UKOSS and confidential enquiries into maternal deaths is how the UK learns from cases. Anyone who has experienced AFE can ask the trust for a debrief and for information about how their case was reviewed.
Frequently asked
Questions people ask.
Quick, plain-English answers to the questions we hear most.
-
What is amniotic fluid embolism?
It is a rare obstetric emergency in which a woman suddenly collapses around labour or birth with heart, breathing and clotting problems for which no other cause is found. UKOSS defines it clinically or by finding fetal material in the lungs.
-
How common is it?
UKOSS says estimates vary between 1 in 8,000 and 1 in 80,000 pregnancies. A multicountry study estimated 0.8 to 1.8 per 100,000 maternities.
-
Can it be predicted or prevented?
UKOSS says no clear risk factors are identifiable from previous cases. Associated factors such as older age or induction of labour do not make AFE likely, and there is no known way to prevent it.
-
What are the associated factors?
A multicountry study found older maternal age, multiple pregnancy, polyhydramnios, placenta praevia, placental abruption and induction of labour were associated with higher odds.
-
How is it diagnosed?
The UK clinical definition is acute hypotension or cardiac arrest, acute hypoxia or coagulopathy without another explanation, or fetal squames or hair found in the lungs.
-
What treatment is used?
Supportive care for the heart, lungs and blood clotting, with senior obstetric and anaesthetic staff. The multicountry study suggested tranexamic acid and correcting coagulopathy may be important.
-
Do women survive?
Many do. UKOSS notes fatality is decreasing in the UK, but the multicountry study found 30% to 41% died or had permanent neurological injury.
-
Does it affect the baby?
Babies can be affected as well. The sources used here focus on maternal outcomes, so ask the maternity or neonatal team about the baby's care and follow-up.
-
Can it happen again in another pregnancy?
The sources reviewed do not give recurrence figures. An obstetrician can discuss this with you after an event.
-
Who studies AFE in the UK?
UKOSS, run from the National Perinatal Epidemiology Unit at the University of Oxford, collects data on cases, and the UK Confidential Enquiry into Maternal Deaths reviews deaths.
Where this comes from
Sources and checking.
This guide is for information, not medical advice.
Your GP or consultant knows your history and can tell you which parts apply to you. If your symptoms are severe, rapidly worsening, or come with red-flag features, seek urgent medical care. Figures and availability change, so treat them as a guide and confirm with the provider.
Published 2026-10-10, next review 2027-10-10.
-
UKOSS (NPEU, University of Oxford): Amniotic Fluid Embolism, https://www.npeu.ox.ac.uk/ukoss/current-surveillance/amf , retrieved October 2026
-
Fitzpatrick KE et al, PLOS Medicine 2019: Risk factors, management, and outcomes of amniotic fluid embolism, a multicountry population-based study (international research paper led from Oxford, not a UK patient leaflet), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850527/ , retrieved October 2026